132 related articles for article (PubMed ID: 16006969)
1. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
[TBL] [Abstract][Full Text] [Related]
2. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
Okegawa T; Sayne JR; Nutahara K; Pong RC; Saboorian H; Kabbani W; Higashihara E; Hsieh JT
J Urol; 2007 Mar; 177(3):1148-56. PubMed ID: 17296436
[TBL] [Abstract][Full Text] [Related]
3. Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression.
Taura K; Yamamoto Y; Nakajima A; Hata K; Uchinami H; Yonezawa K; Hatano E; Nishino N; Yamaoka Y
J Gene Med; 2004 May; 6(5):526-36. PubMed ID: 15133763
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
5. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228.
Kitazono M; Goldsmith ME; Aikou T; Bates S; Fojo T
Cancer Res; 2001 Sep; 61(17):6328-30. PubMed ID: 11522619
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer.
Murakami J; Asaumi J; Kawai N; Tsujigiwa H; Yanagi Y; Nagatsuka H; Inoue T; Kokeguchi S; Kawasaki S; Kuroda M; Tanaka N; Matsubara N; Kishi K
Cancer Chemother Pharmacol; 2005 Jul; 56(1):22-8. PubMed ID: 15791453
[TBL] [Abstract][Full Text] [Related]
7. Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts.
Vanoosten RL; Moore JM; Ludwig AT; Griffith TS
Mol Ther; 2005 Apr; 11(4):542-52. PubMed ID: 15771957
[TBL] [Abstract][Full Text] [Related]
8. A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells.
Okada T; Uchibori R; Iwata-Okada M; Takahashi M; Nomoto T; Nonaka-Sarukawa M; Ito T; Liu Y; Mizukami H; Kume A; Kobayashi E; Ozawa K
Mol Ther; 2006 Apr; 13(4):738-46. PubMed ID: 16387551
[TBL] [Abstract][Full Text] [Related]
9. Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.
Yamano T; Ura K; Morishita R; Nakajima H; Monden M; Kaneda Y
Mol Ther; 2000 Jun; 1(6):574-80. PubMed ID: 10933982
[TBL] [Abstract][Full Text] [Related]
10. A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma.
Yamamoto S; Yamano T; Tanaka M; Hoon DS; Takao S; Morishita R; Aikou T; Kaneda Y
Cancer Gene Ther; 2003 Mar; 10(3):179-86. PubMed ID: 12637938
[TBL] [Abstract][Full Text] [Related]
11. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
Brüning A; Runnebaum IB
Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells.
Goldsmith ME; Kitazono M; Fok P; Aikou T; Bates S; Fojo T
Clin Cancer Res; 2003 Nov; 9(14):5394-401. PubMed ID: 14614025
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
Sachs MD; Ramamurthy M; Poel Hv; Wickham TJ; Lamfers M; Gerritsen W; Chowdhury W; Li Y; Schoenberg MP; Rodriguez R
Cancer Gene Ther; 2004 Jul; 11(7):477-86. PubMed ID: 15118762
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
17. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems.
Goldsmith ME; Aguila A; Steadman K; Martinez A; Steinberg SM; Alley MC; Waud WR; Bates SE; Fojo T
Mol Cancer Ther; 2007 Feb; 6(2):496-505. PubMed ID: 17308048
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract][Full Text] [Related]
20. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.
Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S
Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
